EUVIMEDEUVIMED entdecken
Crossref

Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer

Tomonobu Uchino iD, Yuna Iwano, Yasunori Miyazaki, Michiaki Nakajo, Misa Osawa, Erina Nagai, Yusuke Taki, Shinsuke Sato, Masaya Watanabe, Masakazu Takagi, Yoshiyuki Kagawa

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-024-04737-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Tomonobu Uchino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uch…. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Esophageal Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: The Research Foundation for Pharmaceutical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAcute Kidney InjuryEsophageal NeoplasmsNeoadjuvant TherapyGlomerular Filtration RateAntineoplastic AgentsCreatinineHumansMaleMiddle AgedFemaleAgedBiomarkersGPI-Linked ProteinsAmidohydrolases

Stichwörter der Autor:innen

Acute kidney injuryCisplatinCreatinine clearanceEstimated glomerular filtration rateSerum creatinineVanin-1

Substanzen

CisplatinpantetheinaseAntineoplastic AgentsCreatinineBiomarkersGPI-Linked ProteinsAmidohydrolases

Autor:innen und Institutionen

  • Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando, Aoi-ku, Shizuoka, 420-8527, Japan. uchinot@u-shizuoka-ken.ac.jp.
  • Department of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
  • Department of Clinical Pharmaceutics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
  • Laboratory of Clinical Pharmacokinetics, the Medical Frontier Center, Shizuoka General Hospital, 4-27-1 Kita Ando, Aoi-ku, Shizuoka, 420-8527, Japan.

ORCID-Profile: Tomonobu Uchino

Förderung

  • The Research Foundation for Pharmaceutical Sciences

Zitieren

APA

Uchino, T., Iwano, Y., Miyazaki, Y., Nakajo, M., Osawa, M., Nagai, E., Taki, Y., Sato, S., Watanabe, M., Takagi, M., & Kagawa, Y. (2025). Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04737-6

Vancouver

Uchino T, Iwano Y, Miyazaki Y, Nakajo M, Osawa M, Nagai E, et al. Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04737-6

BibTeX
@article{Uchino2025,
  author = {Uchino, Tomonobu and Iwano, Yuna and Miyazaki, Yasunori and Nakajo, Michiaki and Osawa, Misa and Nagai, Erina and Taki, Yusuke and Sato, Shinsuke and Watanabe, Masaya and Takagi, Masakazu and Kagawa, Yoshiyuki},
  title = {Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-024-04737-6}
}
Kostenlos starten →